Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy M Frech

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2020
Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults With Early Diffuse Cutaneous Systemic SclerosisElana J Bernstein, Sara Jaafar, Shervin Assassi, et al.
Arthritis Care & Research|February 24, 2018
Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic SclerosisJohn D Pauling, Robyn T Domsic, Lesley A Saketkoo, et al.
Journal of Medical Case Reports|June 10, 2015
Cardiac metabolomics and autopsy in a patient with early diffuse systemic sclerosis presenting with dyspnea: a case reportTracy M Frech, Monica P Revelo, John J Ryan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2020
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic SclerosisRobert Spiera, Laura Hummers, Lorinda Chung, et al.
Clinical Rheumatology|November 1, 2019
Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registryVictoria K Shanmugam, Tracy M Frech, Virginia D Steen, et al.
Seminars in Arthritis and Rheumatism|July 2, 2026
Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosisAradhna Agarwal, Dahlia Hassan, Suiyuan Huang, et al.
Clinical Rheumatology|October 23, 2020
Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?Tracy M Frech, John M VanBuren, Emily Startup, et al.
ACR Open Rheumatology|April 23, 2022
Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United StatesElana J Bernstein, Shervin Assassi, Flavia V Castelino, et al.
International Journal of Rheumatic Diseases|November 29, 2021
Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registryFlavia V Castelino, John M VanBuren, Emily Startup, et al.
Clinical and Experimental Rheumatology|July 27, 2023
The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessationSarah Luebker, Tracy M Frech, Shervin Assassi, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2020
Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults With Early Diffuse Cutaneous Systemic SclerosisElana J Bernstein, Sara Jaafar, Shervin Assassi, et al.
Arthritis Care & Research|February 24, 2018
Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic SclerosisJohn D Pauling, Robyn T Domsic, Lesley A Saketkoo, et al.
Journal of Medical Case Reports|June 10, 2015
Cardiac metabolomics and autopsy in a patient with early diffuse systemic sclerosis presenting with dyspnea: a case reportTracy M Frech, Monica P Revelo, John J Ryan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2020
Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic SclerosisRobert Spiera, Laura Hummers, Lorinda Chung, et al.
Clinical Rheumatology|November 1, 2019
Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registryVictoria K Shanmugam, Tracy M Frech, Virginia D Steen, et al.
Seminars in Arthritis and Rheumatism|July 2, 2026
Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosisAradhna Agarwal, Dahlia Hassan, Suiyuan Huang, et al.
Clinical Rheumatology|October 23, 2020
Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?Tracy M Frech, John M VanBuren, Emily Startup, et al.
ACR Open Rheumatology|April 23, 2022
Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United StatesElana J Bernstein, Shervin Assassi, Flavia V Castelino, et al.
International Journal of Rheumatic Diseases|November 29, 2021
Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registryFlavia V Castelino, John M VanBuren, Emily Startup, et al.
Clinical and Experimental Rheumatology|July 27, 2023
The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessationSarah Luebker, Tracy M Frech, Shervin Assassi, et al.
Pageof 11